Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2021 - gut.bmj.com
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2020 - cir.nii.ac.jp
抄録< jats: p> Following the success of immune checkpoint blockers (ICBs) in different
cancer types, a large number of studies are currently investigating ICBs in patients with …
cancer types, a large number of studies are currently investigating ICBs in patients with …
[HTML][HTML] Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2021 - ncbi.nlm.nih.gov
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups.
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2020 - europepmc.org
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
[PDF][PDF] Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - 2020 - scholar.archive.org
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
[PDF][PDF] Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2020 - gut.bmj.com
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2021 - search.proquest.com
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2021 - pubmed.ncbi.nlm.nih.gov
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups.
M Pinter, B Scheiner, M Peck-Radosavljevic - Gut, 2020 - europepmc.org
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a
large number of studies are currently investigating ICBs in patients with hepatocellular …
large number of studies are currently investigating ICBs in patients with hepatocellular …